Development and Evaluation CAT and Youth
Public ClinicalTrials.gov record NCT05950672. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Development and Evaluation of a Novel Cat Assisted Training (CAT) Intervention for Youth With Developmental Disabilities and Their Family Cat
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This R21 provides a multidisciplinary One Health approach to developing and evaluating a novel Cat Assisted Training (CAT) animal assisted intervention (AAI) for early adolescents with developmental disabilities (DD) and their family cat. Cat social behavior and welfare is heavily influenced by human behavior and training, making it highly likely that cats would also benefit from this program. There remains a critical need for further empirical evaluation of AAI practices, especially those that target the specific needs of youth with disabilities. Further extending the development and evaluation of activity-based AAIs beyond those that include dogs and horses also helps address the critical need to consider and include diverse human participants, creating new equitable opportunities for AAI involvement to those who may have access to cats, but not dogs and horses (due to practical, health, cultural, socio-economic, or other personal reasons).
Study identification
- NCT ID
- NCT05950672
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 36 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 8 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 29, 2023
- Primary completion
- Jun 28, 2025
- Completion
- Aug 20, 2025
- Last update posted
- Apr 12, 2026
2023 – 2025
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Oregon State University | Corvallis | Oregon | 97331 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05950672, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 12, 2026 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05950672 live on ClinicalTrials.gov.